Enhanced mRNA Performance by PCR-Based Manufacturing

Time: 11:00 am
day: Day 2 Track 2 AM

Details:

  • Showcasing a versatile, scalable, and robust GMP mRNA manufacturing platform. 
  • Overcome the limitations of the conventional plasmid-based processes with a scalable PCR-based strategy
  • Within a case study, we contrast the performance of conventional and PCR-based mRNA manufacturing

Speakers: